Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Receptor-mediated Endocytosis01:20

Receptor-mediated Endocytosis

7.4K
Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
7.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sexual Quality of Life after vNOTES Surgery: A Systematic Literature Review.

Journal of minimally invasive gynecology·2026
Same author

Towards HDV Elimination Through HBV Vaccination: Global Strategies, Challenges, and Policy Gaps.

Vaccines·2026
Same author

Catch me if you can! Is there protection from HCV (re)infection?

Gut·2026
Same author

RETRACTED: Bilyy et al. Rapid Generation of Coronaviral Immunity Using Recombinant Peptide Modified Nanodiamonds. <i>Pathogens</i> 2021, <i>10</i>, 861.

Pathogens (Basel, Switzerland)·2025
Same author

A new chemotype that opens the S2∗ pocket of the 3CL protease exhibits antiviral activity against SARS-CoV-2.

European journal of medicinal chemistry·2025
Same author

Laparoscopic Management of Cervical Agenesis: A Rare Case Report.

Journal of minimally invasive gynecology·2025

Related Experiment Video

Updated: Jan 1, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.6K

Recent advances in hepatitis C virus cell entry.

Birke Bartosch1,2,3, Jean Dubuisson4,5,6

  • 1INSERM, U871, 69003 Lyon, France.

Viruses
|October 14, 2011
PubMed
Summary
This summary is machine-generated.

Hepatitis C virus (HCV) entry into liver cells involves complex interactions with host lipid metabolism. Understanding these molecular events and cellular co-factors is key to developing new antiviral strategies for chronic hepatitis C infection.

Keywords:
cell entryhepatitis C virus

More Related Videos

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

30.7K
Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

11.9K

Related Experiment Videos

Last Updated: Jan 1, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.6K
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

30.7K
Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

11.9K

Area of Science:

  • Virology
  • Hepatology
  • Molecular Biology

Background:

  • Hepatitis C virus (HCV) chronically infects over 170 million people globally, leading to severe liver disease.
  • Chronic HCV infection persists in 50-85% of patients, often resulting in fibrosis, cirrhosis, and hepatocellular carcinoma.
  • HCV's unique life cycle and interaction with host lipid metabolism, particularly triglycerides, influence its presence with lipoproteins in patient serum.

Purpose of the Study:

  • To review the molecular mechanisms of HCV cell entry.
  • To elucidate the roles of cellular co-factors in HCV infection.
  • To explore how lipoprotein association affects HCV entry.

Main Methods:

  • Literature review focusing on molecular events in HCV cell entry.
  • Analysis of the roles of identified cellular co-factors.
  • Discussion of the impact of lipoprotein association on viral entry.

Main Results:

  • HCV cell entry is a multi-step process involving specific cellular receptors.
  • Key cellular co-factors implicated include low-density lipoprotein receptor, scavenger receptor BI, occludin, claudin-1, and CD81.
  • HCV's association with lipoproteins appears to modulate its entry efficiency.

Conclusions:

  • The interaction between HCV and host lipid metabolism is crucial for viral entry.
  • Cellular co-factors play indispensable roles in mediating HCV attachment and entry.
  • Further research into these interactions may reveal novel therapeutic targets for hepatitis C.